CEO to take break from running Germany's Uniper for cancer treatment
Reuters
Published Aug 01, 2018 10:19AM ET
CEO to take break from running Germany's Uniper for cancer treatment
BERLIN (Reuters) - The chief executive of Germany's Uniper (DE:UN01), Klaus Schaefer, will take a break from running the company while he is being treated for cancer, the utility said.
"Klaus Schaefer has informed the Chairman of the Supervisory Board, Dr. Bernhard Reutersberg, that he is suffering from cancer and that the treatment will take several months," Uniper said in a statement on Wednesday.
Uniper's supervisory and management boards will now arrange how to divide up Schaefer's duties during his absence, the company said in a short statement.
Schaefer, 51, has been CEO since Jan 1, 2016, when the company began operating as a separate unit of E.ON (DE:EONGn).
He has vowed to defend the energy group's independence, after Finnish rival Fortum (HE:FORTUM) agreed a 3.8 billion euro deal to buy around 47 percent of Uniper from E.ON.
His opposition to the deal had prompted activist investor Elliott to try to launch a probe into whether managers had actively worked to obstruct the sale. A vote on the motion was delayed in June, leaving the fate of Uniper management in Fortum's hands.
Fortum said last month that it was seeking to reset its relationship with Uniper.
Carmaker Fiat Chrysler (MI:FCHA) had to scramble to appoint a successor to its chief executive, Sergio Marchionne, last month when it emerged he was seriously ill and died within days.
After a Swiss hospital said it had been treating Marchionne for more than a year, questions were raised about how much the company knew before it made the situation public.
Fiat Chrysler said that, due to medical privacy, it had no knowledge of the facts relating to Marchionne's health.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.